Description: |
Iin accordance with longstanding U.S. obligations under the Montreal Protocol, seven metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. [Source: FDA]
|
|